RNVU1-1

Across TCGA pan-cancer cohorts, RNVU1-1 RNA is linked to patient survival in 18 of 34 cancer types, making it the most broadly survival-associated RNVU1-1 data layer.

The strongest signal is observed in acute myeloid leukemia (LAML), where higher RNVU1-1 RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated RNVU1-1 expression acts as an unfavorable survival marker, although some lineages such as LAML and HNSC show a favorable association.

LAML, COAD, and HNSC are the cancer types where RNVU1-1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LAML	DFS	Median	All	0.694	0.450	<.001	44	view →
COAD	DFS	Quartile	All	0.450	0.643	.002	40	view →
HNSC	DFS	Tertile	All	0.787	0.625	.002	33	view →
STAD	OS	Median	II,III,IV	0.420	0.647	.013	25	view →
THCA	DFS	Quartile	II,III,IV	0.608	0.915	.001	24	view →
MESO	OS	Quartile	IV	0.151	0.674	.004	18	view →
READ	DFS	Median	III,IV	0.526	0.950	<.001	18	view →
LIHC	OS	Median	III,IV	0.576	0.212	.012	16	view →
LUAD	DFS	Tertile	All	0.574	0.725	.010	13	view →
THYM	DFS	Tertile	II,III,IV	1.000	0.624	.026	8	view →
SKCM	OS	Tertile	IV	1.000	0.235	.027	6	view →
CESC	OS	Quartile	All	0.464	0.724	.034	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 18 lineages.

RNVU1-1–LAML (DFS)

Open the LAML breakdown →